Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Elizabeth David to Aged

This is a "connection" page, showing publications Elizabeth David has written about Aged.

 
Connection Strength
  
 
 
0.508
  
  1. Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg. 2024 Summer; 36(2):261-270.
    View in: PubMed
    Score: 0.059
  2. Toubat O, Atay SM, Kim AW, Ding L, Farias AJ, Ebner PJ, McFadden PM, David EA. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020 05; 109(5):1512-1520.
    View in: PubMed
    Score: 0.049
  3. Ebner PJ, Ding L, Kim AW, Atay SM, Yao MJ, Toubat O, McFadden PM, Balekian AA, David EA. The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2020 01; 109(1):225-232.
    View in: PubMed
    Score: 0.048
  4. David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ. Survival benefits associated with surgery for advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1620-1628.
    View in: PubMed
    Score: 0.045
  5. David EA, Andersen SW, Beckett LA, Melnikow J, Kelly K, Cooke DT, Brown LM, Canter RJ. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2017 Nov; 104(5):1665-1672.
    View in: PubMed
    Score: 0.042
  6. David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ. The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung?Cancer. J Thorac Oncol. 2017 11; 12(11):1636-1645.
    View in: PubMed
    Score: 0.042
  7. David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Ann Thorac Surg. 2017 Jan; 103(1):226-235.
    View in: PubMed
    Score: 0.039
  8. David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct; 102(4):1101-9.
    View in: PubMed
    Score: 0.038
  9. Cooke DT, Gandara DR, Goodwin NC, Calhoun RF, Lara PN, Mack PC, David EA. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):36-40.
    View in: PubMed
    Score: 0.033
  10. Dyas AR, Bronsert MR, Stuart CM, Thomas MB, Schulick RD, Franco SR, Gleisner A, Randhawa SK, David EA, Mitchell JD, Meguid RA. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States. J Thorac Cardiovasc Surg. 2024 Aug; 168(2):378-390.e7.
    View in: PubMed
    Score: 0.016
  11. Stuart CM, Dyas AR, Bronsert MR, Abrams BA, Kelleher AD, Colborn KL, Randhawa SK, David EA, Mitchell JD, Meguid RA. Perioperative hypothermia in robotic-assisted thoracic surgery: Incidence, risk factors, and associations with postoperative outcomes. J Thorac Cardiovasc Surg. 2024 Jun; 167(6):1979-1989.e1.
    View in: PubMed
    Score: 0.016
  12. Wong LY, Parsons N, David EA, Burfeind W, Berry MF. The Impact of Age and Need for Emergent Surgery in Paraesophageal Hernia Repair Outcomes. Ann Thorac Surg. 2023 07; 116(1):138-145.
    View in: PubMed
    Score: 0.015
  13. Yin V, Pagteilan J, Atay SM, David EA, Kim AW, Wightman SC. Esophagectomy for Permanent Mesh Migration After Transthoracic Hiatal Hernia Repair. Ann Thorac Surg. 2022 08; 114(2):e89-e91.
    View in: PubMed
    Score: 0.014
  14. Zhao J, Nguyen A, Ding L, David EA, Atay SM, Wightman SC, McFadden PM, Kim AW. Trends in pneumonectomy for treatment of small-cell lung cancer. Asian Cardiovasc Thorac Ann. 2020 Nov; 28(9):583-591.
    View in: PubMed
    Score: 0.013
  15. Xu E, David EA, Ding L, Atay SM, McFadden PM, Wightman SC, Kim AW. Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer. J Surg Oncol. 2020 Aug; 122(2):320-327.
    View in: PubMed
    Score: 0.013
  16. Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, Stamnes S, Lechtholz-Zey E, Wightman SC, Detterbeck FC, Kim AW. A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020 Jul; 160(1):306-314.e14.
    View in: PubMed
    Score: 0.012
  17. Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314.
    View in: PubMed
    Score: 0.010
  18. Sparrow P, David E, Pugash R. Direct percutaneous jejunostomy--an underutilized interventional technique? Cardiovasc Intervent Radiol. 2008 Mar-Apr; 31(2):336-41.
    View in: PubMed
    Score: 0.005
  19. Woolner LB, David E, Fontana RS, Andersen HA, Bernatz PE. In situ and early invasive bronchogenic carcinoma. Report of 28 cases with postoperative survival data. J Thorac Cardiovasc Surg. 1970 Aug; 60(2):275-90.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)